Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress

被引:220
作者
Clapp, BR [1 ]
Hingorani, AD [1 ]
Kharbanda, RK [1 ]
Mohamed-Ali, V [1 ]
Stephens, JW [1 ]
Vallance, P [1 ]
MacAllister, RJ [1 ]
机构
[1] UCL, Dept Med, BHF Labs, Ctr Clin Pharmacol,Rayne Inst, London WC1E 6JJ, England
关键词
endothelium; nitric oxide; inflammation; coronary disease; reactive oxygen species;
D O I
10.1016/j.cardiores.2004.06.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Our aim was to investigate mechanisms of inflammation-induced endothelial dysfunction in humans. Methods: Endothelial function in twenty-one healthy human volunteers was measured using forearm venous plethysmography before and 8 h after administration of typhoid vaccination to generate an inflammatory response. Basal and stimulated endothelial nitric oxide (NO) bioavailability was assessed by measurement of the responses to intra-arterial N-G-monomethyl-L-arginine (L-NMMA) and bradykinin, respectively. The effects of supplementation with L-arginine or ascorbic acid were assessed to probe the effects of substrate deficiency and oxidative stress, respectively. Systemic effects were determined by measuring cytokine response, total anti-oxidant status (TAOS) and urinary protein excretion. Results: Vaccination induced a cytokine response, a fall in total anti-oxidant status and increased urinary albumin excretion (UAE). There was a reduction in the response to bradykinin (BK, P<0.005) and L-NMMA (P<0.0001) with no effect on the response to glyceryl trinitrate (GTN) and norepinephrine (NE). Following vaccination blood flow response to BK (but not GTN) was partially returned to pre-vaccine levels by infusion of ascorbic acid (P=0.01). Supplementation with L-arginine had no effect. Conclusion: Inflammation causes widespread endothelial dysfunction, reduces vascular NO bioavailability and increases oxidative stress. These actions are partially reversible with local anti-oxidants. These findings suggest a role for reactive oxygen species in inflammation-induced endothelial dysfunction. (C) 2004 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:172 / 178
页数:7
相关论文
共 36 条
[1]   Predictive value of microalbuminuria in medical ICU patients - Results of a pilot study [J].
Abid, O ;
Sun, QH ;
Sugimoto, K ;
Merean, D ;
Vincent, JL .
CHEST, 2001, 120 (06) :1984-1988
[2]   MEASURING FOREARM BLOOD-FLOW AND INTERPRETING THE RESPONSES TO DRUGS AND MEDIATORS [J].
BENJAMIN, N ;
CALVER, A ;
COLLIER, J ;
ROBINSON, B ;
VALLANCE, P ;
WEBB, D .
HYPERTENSION, 1995, 25 (05) :918-923
[3]   Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo [J].
Bhagat, K ;
Vallance, P .
CIRCULATION, 1997, 96 (09) :3042-3047
[4]  
Bombeli T, 1997, THROMB HAEMOSTASIS, V77, P408
[5]   Hypertension does not account for the accelerated atherosclerosis and development of aneurysms in male apolipoprotein E/endothelial nitric oxide synthase double knockout mice [J].
Chen, JQ ;
Kuhlencordt, PJ ;
Astern, J ;
Gyurko, R ;
Huang, PL .
CIRCULATION, 2001, 104 (20) :2391-2394
[6]   Human forearm venous occlusion plethysmography: methodology, presentation and analysis [J].
Chin-Dusting, JPF ;
Cameron, JD ;
Dart, AM ;
Jennings, GLR .
CLINICAL SCIENCE, 1999, 96 (05) :439-440
[7]  
Clausen P, 2001, CIRCULATION, V103, P1869
[8]   L-ARGININE IMPROVES ENDOTHELIUM-DEPENDENT VASODILATION IN HYPERCHOLESTEROLEMIC HUMANS [J].
CREAGER, MA ;
GALLAGHER, SJ ;
GIRERD, XJ ;
COLEMAN, SM ;
DZAU, VJ ;
COOKE, JP .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (04) :1248-1253
[9]   IMPAIRED VASODILATION OF FOREARM RESISTANCE VESSELS IN HYPERCHOLESTEROLEMIC HUMANS [J].
CREAGER, MA ;
COOKE, JP ;
MENDELSOHN, ME ;
GALLAGHER, SJ ;
COLEMAN, SM ;
LOSCALZO, J ;
DZAU, VJ .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (01) :228-234
[10]   Acute administration of L-arginine does not improve arterial endothelial function in chronic renal failure [J].
Cross, JM ;
Donald, AE ;
Kharbanda, R ;
Deanfield, JE ;
Woolfson, RG ;
MacAllister, RJ .
KIDNEY INTERNATIONAL, 2001, 60 (06) :2318-2323